personalised medicine
Roche highlights R&D promise after setbacks
December 9, 2010Research and Development MS, Roche, oncology, personalised medicine, schizophrenia
Roche has presented its pipeline to shareholders to boost confidence that it can sustain the spectacular growth of recent years. …
Pharma unprepared for personalised oncology
November 29, 2010Research and Development, Sales and Marketing Cancer, ESMO, ESMO Cancer Biology for Clinicians Symposium, oncology, personalised medicine
The new era of personalised cancer care requires different thinking from pharma companies, according to experts at the ESMO symposium. …
Cutting-edge cancer treatments showcased at ESMO
October 18, 2010Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine
The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …
Roche investing $180m on US diagnostics facilities
October 18, 2010Research and Development Diagnostics, Roche, Ventana, personalised medicine
Swiss drugmaker Roche is planning to invest $180 million and boost staff at its diagnostics subsidiary Ventana Medical Systems, as …
UK invests £50m in targeted research
October 13, 2010Research and Development BIA, clinical research, genomics, personalised medicine, targeting
The government is to put more than £50 million of funding into a new initiative to produce more targeted research …
Study boost for personalised cancer treatments
July 23, 2010Research and Development Cancer, genome, genomics, personalised medicine
A five-year study by scientists in the UK and US of the way genomes and cancer medicines interact has yielded …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
